Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




FDA Approvals: Diovan, Renvela, Humate-P
Link ID 1544
Title FDA Approvals: Diovan, Renvela, Humate-P
Url http://www.medscape.com/viewarticle/567405?src=rss
Description The FDA has approved an expanded indication for valsartan tablets, sevelamer carbonate tablets, and new storage conditions for factor VIII/von Willebrand factor complex intravenous injection. Medscape Medical News
Category Articles > Cardiology
Keywords
Date Dec 14, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Cardiology
1. More Support for Statins in Diabetics
  An analysis from the Cholesterol Treatment Trialists indicates that statins reduce the risk for major vascular events and mortality, even in people with diabetes and no vascular disease at baseline. Medscape Medical News
Category:   Articles > Cardiology


2. Management of Elevated Cholesterol in a Patient With Previous MI
  Dr. Karas educates readers about risk factors for CVD, predicting CVD risk, and managing high lipid levels in patients with existing CVD. Medscape Cardiology
Category:   Articles > Cardiology


3. Thrombus Aspiration Feasible, Results in Better Reperfusion and Clinical Outcomes in Acute-MI Patien
  Investigators say that manual aspiration can be performed in a large majority of patients presenting with ST-segment-elevation MI, irrespective of baseline clinical and angiographic features, such as a visible thrombus on angiography. Caution, however, is needed, as the study was single center and PCI performed by experienced operators. Heartwire
Category:   Articles > Cardiology


4. Red Yeast Extract Reduces Major Coronary Events in Large, Randomized Clinical Trial
  Chinese red yeast rice extract reduced the risk for major coronary events by almost 50% as well as the risk for cardiovascular and total mortality in patients with a previous myocardial infarction. Medscape Medical News
Category:   Articles > Cardiology


5. No Neuroprotective Effect of Dipyridamole, Aspirin, or Telmisartan in Recurrent Stroke
  In this third factorial analysis of the PROFESS trial, researchers found no sign of neuroprotection from a recurrent stroke with dipyridamole, aspirin, or telmisarta Medscape Medical News
Category:   Articles > Cardiology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS